Global Community
Our community narratives are driven by numbers and valuation.
Community Investing Ideas
Global Weekly Picks
AMD’s Game-Changing Q3 Highlights
Advanced Micro Devices, Inc. (AMD) continues to thrive in the semiconductor industry, leveraging strategic expansions and innovations against surging demand driven by AI and data center growth.Read more
Navigating the Future: Analysis of Tesla's Growth and Challenges
Catalysts FSD (Supervised): This is Tesla's Full Self-Driving technology. As it progresses towards full autonomy, consider the potential for mass adoption and its impact on Tesla's brand and sales.Read more
International Store Growth To Sustain Revenue Growth Despite Labour Headwinds
Key Takeaways Store growth plans to increase by 74% internationally, but only 12% in the US. Coffee demand is expected to be a tailwind for revenues longer term, growing at a stable 4.2%.Read more
potential stock price of Aris Mining at $4,000 per ounce of gold
To calculate the potential stock price of Aris Mining at $4,000 per ounce of gold, we would follow these steps: 1. Current Production Metrics: - By the end of 2025, Aris expects to be mining around 450,000 oz annually.Read more
at a gold price of $4,000 per oz
To estimate the potential stock price for Gowest Gold based on their Bradshaw project, we’ll analyze projected production, costs, potential free cash flow, and market valuation. Step 1: Production Forecast and Revenue Calculation 1.Read more
Global Direct-To-Consumer Growth May Reduce Nike’s Premium
Key Takeaways While Direct-To-Consumer sales may improve Nike’s margins, it will make it harder for the company to retain their market share. The market is more accessible and Nike has to find ways to stay ahead of marketplaces, retailers, fast fashion brands, outlets, etc.Read more
SGR Turn around or take over?
Catalysts: The company will remediate their issues with the government and get their casino licence back, however, this is likely to take many years. An external player makes a take over offer that investors can't refuse.Read more
Merck & Co.: Navigating Pharmaceutical Frontiers Amidst Patent Challenges
Executive Summary: Merck & Co., a pharmaceutical powerhouse, faces a pivotal moment balancing its innovative strengths against looming patent expirations. This analysis delves into the company's strategic positioning and its implications for investors.Read more
Biotech longerterm bet
211011 Draupnir noch ein Anteil von rund 55,5% an Polypeptide. Der «Free Float» an der Börse SIX erhöht sich dadurch gleichzeitig von 40,0 auf rund 44,5%.Read more
